Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Bearsden Road, Glasgow, G61 1QH, UK.
SAC Consulting: Veterinary Services, SRUC Veterinary Services, Pentland Science Park, Bush Loan, Penicuik, Midlothian, EH26 0PZ, UK.
Vet Res. 2020 Feb 5;51(1):9. doi: 10.1186/s13567-020-0737-9.
Genetic variation is associated with differences in disease resistance and susceptibility among individuals within a population. To date, molecular genetic analyses of host responses have relied on extraction of genomic DNA from whole blood or tissue samples. However, such samples are not routinely collected during large-scale field studies. We demonstrate that cell-free genomic DNA (cfDNA) may be extracted and amplified from archived plasma samples, allowing retrospective analysis of host genetic diversity. This technique was also applicable to archived serum samples up to 35 years old and to different ruminant species. As proof of concept, we used this cfDNA approach to genotype the major histocompatibility complex (MHC) class II DRB1 locus of 224 Merino sheep which had participated in field trials of a commercial Haemonchus contortus vaccine, Barbervax, in Australia. This identified a total of 51 different DRB1 alleles and their relative frequencies. This is the first study to examine host MHC diversity using DNA extracted from archived plasma samples, an approach that may be applied to retrospective analyses of genetic diversity and responses to vaccination or infection across different species and populations.
遗传变异与人群中个体对疾病的抵抗力和易感性的差异有关。迄今为止,对宿主反应的分子遗传分析依赖于从全血或组织样本中提取基因组 DNA。然而,在大规模野外研究中,此类样本通常无法采集。我们证明,可从存档的血浆样本中提取和扩增无细胞基因组 DNA(cfDNA),从而可对宿主遗传多样性进行回顾性分析。该技术还适用于长达 35 年的存档血清样本以及不同的反刍动物物种。作为概念验证,我们使用该 cfDNA 方法对 224 只曾参与澳大利亚 Haemonchus contortus 疫苗商业制剂 Barbervax 田间试验的美利奴绵羊的主要组织相容性复合体(MHC)II 类 DRB1 基因座进行了基因分型,共鉴定出 51 个不同的 DRB1 等位基因及其相对频率。这是第一项使用从存档血浆样本中提取的 DNA 来研究宿主 MHC 多样性的研究,该方法可用于对不同物种和群体的遗传多样性和疫苗接种或感染反应进行回顾性分析。